Position in CYTK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$232,057
+$3,428 QoQ
Shares Held
2,724
-71.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#357
of 477 holders
Holding Since
Jun 2020
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sigma Planning Corp holds $8,143,454 across 16 Biotechnology names. CYTK ranks #12 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | STRO |
Sutro Biopharma, Inc.
|
45,020 | $1,494,664 | |
| 2 | SRPT |
Sarepta Therapeutics, Inc.
|
60,612 | $1,089,197 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
15,375 | $844,702 | |
| 4 | QURE |
uniQure N.V.
|
16,400 | $755,384 | |
| 5 | ASND |
Ascendis Pharma A/S
|
2,290 | $610,788 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
13,221 | $515,751 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,033 | $513,122 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
2,009 | $484,108 |
All Filings in CYTK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $232,057 | 2,724 | Shares | Sole | 2026-08-07 | |
| 2020-06-30 | $228,629 | 9,700 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||